FDA Plans Tighter Scrutiny Of Off-Label Data Sent To Doctors
The U.S. Food and Drug Administration is preparing more stringent guidelines on how pharmaceutical companies and similar firms should communicate with doctors about research into the off-label use of medical devices...To view the full article, register now.
Already a subscriber? Click here to view full article